• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重慢性肾衰竭患者中头孢哌酮的血清和尿液浓度

Serum and urine concentrations of cefoperazone in severe chronic renal failure.

作者信息

Bailey R R, Peddie B, Blake E

出版信息

Drugs. 1981;22 Suppl 1:46-51. doi: 10.2165/00003495-198100221-00011.

DOI:10.2165/00003495-198100221-00011
PMID:6456891
Abstract

Two studies evaluating the efficacy of cefoperazone in patients with chronic renal failure are described. In study A, 10 patients with severe chronic renal failure were given 1 g of cefoperazone intravenously over 3 minutes. The mean serum cefoperazone concentration at 30 minutes was 119.3 +/- 15.7 microgram/ml, and at 6 hours was 35.9 +/- 5.7 micrograms/ml. The mean serum half-life using the method of least squares was 6.6 +/- 1.15 hours (range, 2.5 to 15.1). The mean half-life from 2 hours onwards was 12.2 +/- 3.51 hours (range, 2.3 to 42.9). The mean peak urinary concentration of cefoperazone was 192 microgram/ml with a very wide individual range of 20 to 920 microgram/ml which was reached 0.5 to 9 hours after injection. In study B, 8 patients with chronic renal failure were treated with 1 to 2 g of cefoperazone intravenously every 12 hours for 5 to 14 days for complicated urinary tract infections. Serum and urine concentrations of cefoperazone were measured 6 hours after each morning dose. The mean 6-hour serum and urine concentrations of cefoperazone for the 4 patients treated with 2 g daily were 63 +/- 11.7 and 87 +/- 11.1 microgram/ml, respectively. The corresponding values for the 4 patients treated with 4 g daily were 106 +/- 20 and 258 +/- 32 microgram/ml. No drug accumulation occurred in any patient. No deterioration in renal function was noted. In conclusion, cefoperazone promises to be an effective and safe broad-spectrum antibiotic for patients with all degrees of renal function impairment. A dosage schedule of 2 to 4 g daily will not lead to significant drug accumulation in the presence of severe renal failure.

摘要

本文描述了两项评估头孢哌酮对慢性肾衰竭患者疗效的研究。在研究A中,10例严重慢性肾衰竭患者在3分钟内静脉注射1g头孢哌酮。30分钟时头孢哌酮的平均血清浓度为119.3±15.7μg/ml,6小时时为35.9±5.7μg/ml。采用最小二乘法计算的平均血清半衰期为6.6±1.15小时(范围为2.5至15.1小时)。从2小时起的平均半衰期为12.2±3.51小时(范围为2.3至42.9小时)。头孢哌酮的平均尿峰浓度为192μg/ml,个体差异范围很大,为20至920μg/ml,在注射后0.5至9小时达到。在研究B中,8例慢性肾衰竭患者因复杂性尿路感染,每12小时静脉注射1至2g头孢哌酮,持续5至14天。每天早晨给药后6小时测量头孢哌酮的血清和尿液浓度。每天接受2g治疗的4例患者的头孢哌酮平均6小时血清和尿液浓度分别为63±11.7和87±11.1μg/ml。每天接受4g治疗的4例患者的相应值为106±20和258±32μg/ml。所有患者均未出现药物蓄积。未观察到肾功能恶化。总之,头孢哌酮有望成为一种对所有程度肾功能损害患者均有效且安全的广谱抗生素。在严重肾衰竭的情况下,每日2至4g的给药方案不会导致明显的药物蓄积。

相似文献

1
Serum and urine concentrations of cefoperazone in severe chronic renal failure.严重慢性肾衰竭患者中头孢哌酮的血清和尿液浓度
Drugs. 1981;22 Suppl 1:46-51. doi: 10.2165/00003495-198100221-00011.
2
Pharmacokinetics of cefoperazone: a review.
Drugs. 1981;22 Suppl 1:35-45. doi: 10.2165/00003495-198100221-00010.
3
[Pharmacokinetics of a new cephalosporin, cefoperazone].
Schweiz Med Wochenschr. 1979 Dec 29;109(50):1999-2005.
4
Cefoperazone in the treatment of severe or complicated infections.
Drugs. 1981;22 Suppl 1:76-86. doi: 10.2165/00003495-198100221-00017.
5
Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.头孢哌酮在肝肾功能正常和受损患者中的药代动力学。
Rev Infect Dis. 1983 Mar-Apr;5 Suppl 1:S127-36. doi: 10.1093/clinids/5-supplement_1.s127.
6
Pharmacokinetics of cefoperazone in patients with neoplastic disease.头孢哌酮在肿瘤疾病患者中的药代动力学。
Antimicrob Agents Chemother. 1981 Jun;19(6):1037-41. doi: 10.1128/AAC.19.6.1037.
7
[Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain].[一种头孢菌素的药代动力学研究:用于有克尔引流管的患者的头孢哌酮]
Schweiz Med Wochenschr. 1982 Jan 23;112(4):123-9.
8
A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.头孢哌酮的药代动力学综述与总结:一种新型广谱β-内酰胺类抗生素
Ther Drug Monit. 1981;3(2):121-8. doi: 10.1097/00007691-198102000-00002.
9
Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency.头孢哌酮在正常志愿者和肾功能不全受试者中的药代动力学。
Antimicrob Agents Chemother. 1981 May;19(5):821-5. doi: 10.1128/AAC.19.5.821.
10
[Cefoperazone--a new cephalosporin antibiotic with broader spectrum of activity].
Med Klin. 1981 Feb 13;76(4):102-6, 70.

引用本文的文献

1
Application of Aluminum Hydroxide for Improvement of Label-Free SERS Detection of Some Cephalosporin Antibiotics in Urine.氢氧化铝在提高尿液中某些头孢菌素抗生素无标记 SERS 检测中的应用。
Biosensors (Basel). 2019 Jul 23;9(3):91. doi: 10.3390/bios9030091.
2
Complicated urinary tract infection in adults.成人复杂性尿路感染。
Can J Infect Dis Med Microbiol. 2005 Nov;16(6):349-60. doi: 10.1155/2005/385768.
3
Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.

本文引用的文献

1
Cefoperazone: absorption, excretion, distribution, and metabolism.头孢哌酮:吸收、排泄、分布及代谢
Clin Ther. 1980;3(Spec Issue):60-79.
2
Single-dose pharmacokinetics of cefoperazone following intravenous administration.
Clin Ther. 1980;3(Spec Issue):46-9.
头孢哌酮:对其体外抗菌活性、药理特性及治疗效果的综述。
Drugs. 1981 Dec;22(6):423-60. doi: 10.2165/00003495-198122060-00002.
4
Cefoperazone pharmacokinetics in normal subjects and patients with cirrhosis.头孢哌酮在正常受试者和肝硬化患者中的药代动力学。
Antimicrob Agents Chemother. 1983 Mar;23(3):385-9. doi: 10.1128/AAC.23.3.385.
5
Clinical pharmacokinetics of the third generation cephalosporins.第三代头孢菌素的临床药代动力学
Clin Pharmacokinet. 1985 Mar-Apr;10(2):101-43. doi: 10.2165/00003088-198510020-00001.
6
Pharmacokinetics of cefoperazone in ambulatory elderly volunteers compared with young adults.头孢哌酮在老年门诊志愿者与年轻成年人中的药代动力学比较。
Antimicrob Agents Chemother. 1987 Jun;31(6):925-9. doi: 10.1128/AAC.31.6.925.
7
Alteration of hemostasis associated with cefoperazone treatment.与头孢哌酮治疗相关的止血改变。
Infection. 1986 Jan-Feb;14(1):27-31. doi: 10.1007/BF01644806.
8
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.肾功能受损患者抗生素的临床药代动力学
Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002.